A detailed history of Investors Research Corp transactions in Zoetis Inc. stock. As of the latest transaction made, Investors Research Corp holds 80 shares of ZTS stock, worth $13,271. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 71 12.68%
Holding current value
$13,271
Previous $12,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$172.58 - $196.48 $1,553 - $1,768
9 Added 12.68%
80 $15,000
Q3 2023

Nov 01, 2023

BUY
$167.14 - $192.77 $1,838 - $2,120
11 Added 18.33%
71 $12,000
Q3 2022

Nov 10, 2022

BUY
$148.29 - $182.55 $5,931 - $7,302
40 Added 200.0%
60 $9,000
Q2 2022

Jul 21, 2022

BUY
$155.97 - $200.09 $3,119 - $4,001
20 New
20 $3,000
Q4 2020

Jan 21, 2021

SELL
$157.07 - $174.35 $5,183 - $5,753
-33 Closed
0 $0
Q1 2019

Apr 23, 2019

BUY
$81.56 - $100.67 $2,691 - $3,322
33 New
33 $3,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Investors Research Corp Portfolio

Follow Investors Research Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

News

Stay updated on Investors Research Corp with notifications on news.